0001225208-24-000071.txt : 20240102 0001225208-24-000071.hdr.sgml : 20240102 20240102174203 ACCESSION NUMBER: 0001225208-24-000071 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231229 FILED AS OF DATE: 20240102 DATE AS OF CHANGE: 20240102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DAMICO JENNIFER B. CENTRAL INDEX KEY: 0001805617 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 24503693 MAIL ADDRESS: STREET 1: C/O PFIZER INC. CORPORATE SECRETARY STREET 2: 235 EAST 42ND STREET CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 BUSINESS PHONE: 2127332323 MAIL ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 4 1 doc4.xml X0508 4 2023-12-29 0000078003 PFIZER INC PFE 0001805617 DAMICO JENNIFER B. 66 HUDSON BOULEVARD EAST ATTN: CORPORATE SECRETARY NEW YORK NY 10001-2192 1 SVP & Controller 0 Phantom Stock Units SSP 2023-12-29 4 A 0 47.0000 28.7900 A Common Stock 47.0000 23475.0000 D Each unit represents one phantom share of common stock. These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Susan E. Grant, by power of atty., for Jennifer B. Damico 2024-01-02